Suppr超能文献

《King's 简要间质性肺病问卷的心理测量特性及其在进行性纤维化间质性肺病患者中治疗反应有意义的阈值》

The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases.

机构信息

Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK

Evidera, PPD, Bethesda, MD, USA.

出版信息

Eur Respir J. 2022 Jun 2;59(6). doi: 10.1183/13993003.01790-2021. Print 2022 Jun.

Abstract

BACKGROUND

There is a lack of fully validated patient-reported outcome measures for progressive fibrosing interstitial lung disease (ILD). We aimed to validate the King's Brief Interstitial Lung Disease (K-BILD) questionnaire for measuring health-related quality of life (HRQoL) in these patients. We also aimed to estimate the meaningful change threshold for interpreting stabilisation of HRQoL as a clinical end-point in progressive fibrosing ILD, where the current goal of treatment is disease stability and slowing progression.

METHODS

This analysis evaluated data from 663 patients with progressive fibrosing ILD other than idiopathic pulmonary fibrosis from the INBUILD trial. Validation of the measurement properties was assessed for internal consistency, test-retest reliability, construct validity, known-groups validity and responsiveness. We calculated meaningful change thresholds for treatment response using anchor-based (within-patient) and distribution-based methods.

RESULTS

K-BILD had strong internal consistency (Cronbach's α was 0.94 for total score, 0.88 for breathlessness and activities, 0.91 for psychological, and 0.79 for chest symptoms). The test-retest reliability intraclass correlation coefficient was 0.74 for K-BILD total score. K-BILD demonstrated weak correlations with forced vital capacity (FVC) percent predicted. Known-groups validity showed significant differences in K-BILD scores for patient groups with different disease severity based on use of supplemental oxygen or baseline FVC % pred (≤70% or >70%). We estimated a meaningful change threshold of ≥ -2 units for K-BILD total score for defining patients who remain stable/improved those with progressive deterioration.

CONCLUSIONS

Our results validate K-BILD as a tool for assessing HRQoL in patients with progressive fibrosing ILD and set a meaningful change threshold of ≥ -2 units for K-BILD total score.

摘要

背景

目前缺乏针对进展性肺纤维化间质性肺病(ILD)的完全验证的患者报告结局测量指标。我们旨在验证 King's Brief Interstitial Lung Disease(K-BILD)问卷,以衡量这些患者的健康相关生活质量(HRQoL)。我们还旨在估计用于解释进展性纤维化ILD 中 HRQoL 稳定作为临床终点的有意义的变化阈值,目前治疗的目标是疾病稳定和减缓进展。

方法

这项分析评估了来自 INBUILD 试验的 663 名非特发性肺纤维化的进展性纤维化 ILD 患者的数据。使用内部一致性、测试-重测可靠性、结构有效性、已知群体有效性和反应性来评估测量特性的验证。我们使用基于锚定(患者内)和基于分布的方法计算治疗反应的有意义的变化阈值。

结果

K-BILD 具有很强的内部一致性(总分为 0.94,呼吸困难和活动评分为 0.88,心理评分为 0.91,胸部症状评分为 0.79)。K-BILD 总分的测试-重测可靠性组内相关系数为 0.74。K-BILD 与用力肺活量(FVC)预测百分比呈弱相关。基于使用补充氧气或基线 FVC%pred(≤70%或>70%)的不同疾病严重程度的患者组之间,K-BILD 评分存在显著差异,表明了 K-BILD 的已知群体有效性。我们估计 K-BILD 总分为≥-2 个单位的有意义变化阈值,用于定义那些保持稳定/改善的患者,而不是那些病情恶化的患者。

结论

我们的结果验证了 K-BILD 作为评估进展性纤维化 ILD 患者 HRQoL 的工具,并为 K-BILD 总分设定了≥-2 个单位的有意义变化阈值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43a0/9160394/254408f9d3e8/ERJ-01790-2021.01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验